2invest

What they do

Originally founded in 1997 as a life sciences operating company, the firm sold its core proteomics business in 2020 and officially restructured into an investment holding company, 2invest AG, in 2021. Backed by major German investment groups like Deutsche Balaton AG and Delphi Unternehmensberatung AG, 2invest operates with an extremely lean team, deploying capital directly from its balance sheet. The firm is uniquely positioned in the market due to its bifurcated focus on early-stage European biotech innovators and global natural resource/mining projects, often leveraging strategic partnerships to source and evaluate deals.

What they look for

2invest AG aims to acquire, hold, manage, and sell investments in corporations and partnerships worldwide. Their objective is to identify and support emerging companies with strong management teams and groundbreaking technologies, enabling them to reach meaningful value inflection points.

Stage

Seed, Series A, Series B+

Sectors

Healthcare, Deeptech

Based

Heidelberg, DE